Q&A Session: The Current Evidence On Telemedicine-Delivered Treatment for Opioid and Other Substance Use Disorders
Recorded On: 10/21/2020
This is the fifth Q & A webinar in the telehealth series for the Opioid Response Network (ORN).
Funding for this initiative was made possible (in part) by grant no. 6H79TI080816 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
Allison Lin, MD
Allison Lin, MD is an addiction psychiatrist and Assistant Professor in the Department of Psychiatry as well as a research investigator at the VA Center for Clinical Management Research. She investigates ways to improve treatment for patients with opioid and other substance use disorders and uses large electronic health datasets to better understand medical, mental health and other correlates for patients with substance use disorders. Dr. Lin is interested in developing telehealth interventions to improve access to evidence based treatments for substance use disorders and to better understand disparities in treatment.
Areas of Interest
· Improving access to opioid and other substance use disorder treatment
· Improving care for patients with substance and other comorbid mental health disorders
· Reducing drug overdose
· Interventions to promote safer opioid prescribing
· Addiction Psychiatry Research & Clinical Fellow, Department of Psychiatry, University of Michigan Medical School
· Adult Psychiatry Residency, Department of Psychiatry, University of Michigan Medical School
· M.D. Yale University School of Medicine B.S. in Chemical Engineering and Economics, Massachusetts Institute of Technology
Julie Kmiec, DO, FAOAAM (Moderator)
Julie Kmiec, DO, graduated from Western University of Health Sciences College of Osteopathic Medicine of the Pacific. She completed her general psychiatry residency training and addiction psychiatry fellowship at Western Psychiatric Institute and Clinic (WPIC) in Pittsburgh, PA. She is currently an Assistant Professor of Psychiatry at the University of Pittsburgh School of Medicine. She is board certified in general and addiction psychiatry. Dr. Kmiec is the Medical Director of the Ambulatory Detoxification Program, Bridge Clinic, and is the founding medical director of the Narcotic Addiction Treatment Program’s Buprenorphine Clinic at WPIC. Her clinical interests include treatment of drug and alcohol withdrawal, prevention of overdose, and pharmacotherapy for the treatment of addictions. Dr. Kmiec’s research involves training healthcare professionals on the implementation of medications for opioid use disorder. She is the President of the American Osteopathic Academy of Addiction Medicine.